ROFLUMILAST

Generic: ROFLUMILAST

AvKAREManufacturer
ORALRoute
ROFLUMILASTActive Substance
2020-03-30Original Approval

ROFLUMILAST is FDA application ANDA208247, sponsored by STRIDES PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DYSPNOEA
454 reports
2
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
250 reports
3
PNEUMONIA
213 reports
4
ASTHMA
207 reports
5
COUGH
192 reports
6
WHEEZING
168 reports
7
DIARRHOEA
167 reports
8
DRUG INEFFECTIVE
158 reports
9
NAUSEA
144 reports
10
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
140 reports